Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Phase 1
Completed
- Conditions
- Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- John Byrd
- Target Recruit Count
- 36
- Registration Number
- NCT00201682
- Locations
- 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States
News
No news found